US National OCS Heart Perfusion (OHP) Registry
Purpose
This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.
Condition
- Heart Transplant
Eligibility
- Eligible Ages
- All ages
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- N/A
Exclusion Criteria
- N/A
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Other
- Time Perspective
- Other
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| OCS Heart Transplant Recipients | All heart transplant recipients who are transplanted with an OCS perfused donor heart are eligible for this registry. |
|
Recruiting Locations
Phoenix, Arizona 85006
Raelyn McGarry
La Jolla, California 92037
Palo Alto, California 94304
Tiffany Koyano
Palo Alto, California 94304
San Francisco, California 94143
Boulder, Colorado 80309
Nargis Kalia, MPH
New Haven, Connecticut 06510
Jacksonville, Florida 32224
Tampa, Florida 33606
Chicago, Illinois 60637
Lexington, Kentucky 40506
Boston, Massachusetts 02114
Boston, Massachusetts 02215
Minneapolis, Minnesota 55407
Minneapolis, Minnesota 55414
Rochester, Minnesota 55905
New York, New York 10032
Valhalla, New York 10595
Chapel Hill, North Carolina 48109
Charlotte, North Carolina 28203
Durham, North Carolina 27710
Cincinnati, Ohio 45219
William Stewart
Pittsburgh, Pennsylvania 15213
Charleston, South Carolina 29425
Dallas, Texas 75226
Dallas, Texas 75390
Salt Lake City, Utah 84132
Richmond, Virginia 23298
Giorgi Mchedkushvili
Seattle, Washington 98105
Milwaukee, Wisconsin 53226
More Details
- NCT ID
- NCT05915299
- Status
- Recruiting
- Sponsor
- TransMedics
Detailed Description
The objective of this US National OHP Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and to document the performance of the OCS Heart device in the real-world setting after FDA approval in the US. The US National OHP Registry will enroll all heart transplant recipients who are transplanted with an OCS-perfused donor heart in the Registry. Patients' clinical outcomes will be followed up to five years post-transplant, loss to follow up, or death, whichever occurs first.